Kombiglyze XR Lawsuit - Magzinenow

Kombiglyze XR Lawsuit

Several studies have been conducted which indicate an increase in the risk of heart failure, aortic aneurysms, and pancreatitis. These conditions have been linked to the use of Kombiglyze XR. If you have been taking this drug and are suffering from one or more of these conditions, you may want to consider filing a lawsuit against the manufacturer.

Heart failure

Hundreds of lawsuits have been filed against AstraZeneca Pharmaceuticals LP and Bristol-Myers Squibb for their allegedly dangerous drugs, Onglyza and Kombiglyze XR. These drugs have been linked to severe side effects, including heart failure.

Patients filed the lawsuits on the grounds that the manufacturers of these drugs concealed information about their risks for heart failure. They also alleged that Bristol-Myers Squibb knew of the increased risks and that they failed to adequately warn patients of their danger.

The FDA issued a safety announcement in 2016, stating that the drug may have increased the risk for heart failure and that they should update the labeling. The panel of experts voted to add a warning to the bottles and to update the labeling to emphasize the risk.

The drug has been linked to a number of other side effects, including pancreatitis and thyroid cancer. If you or a loved one has been suffering from heart failure, a seasoned pharmaceutical liability attorney can advise you of your legal rights. A free case evaluation is also available.

Attorneys say that the number of lawsuits against the manufacturers is expected to continue to increase. The lawsuits allege that the manufacturers of Onglyza and Kombiglyze XR failed to warn patients of their increased risks for heart failure.

In addition, the makers of these drugs sold dangerous medications to the public and to health care providers, relying on misleading statements.

According to the lawsuits, the makers of Onglyza and Kombiglyze XR placed profit before consumer safety. The makers concealed information about their risks for heart failure, which caused many people to suffer cardiovascular injuries.

The makers of these drugs also hid the risks from doctors. According to one study, a person with Type 2 diabetes was up to 27% more likely to be hospitalized for congestive heart failure if they took Onglyza or Kombiglyze XR.

See also  What Is Java: Guide for Beginners

In addition to these lawsuits, surviving family members of those who died from heart failure have also filed a lawsuit against AstraZeneca Pharmaceuticals LP. A lawsuit filed in Kentucky alleges that AstraZeneca failed to adequately test the drug.

Aortic aneurysm

Amongst the hundreds of thousands of prescription medications on hand at any given time, AstraZeneca’s Kombiglyze XR Lawsuit stands out as the best-kept secret of the medicine cabinet. AstraZeneca has not yet revealed the long term consequences of its latest gambit, although it has a lot of good reason to do so. AstraZeneca is no stranger to lawsuits, having been the target of more than its fair share of them over the years. The FDA has already issued a Drug Safety Communication about Kombiglyze XR, although no formal notices have been filed in the interim. If you or a loved one has taken Kombiglyze XR for a plethora of ailments, you may be entitled to a hefty settlement. AstraZeneca is a large and complex entity, and you would be well advised to enlist the services of a seasoned litigator. The cost of a consultation is minimal, and you may be entitled to a sizable payout. The best part is you aren’t stuck in a courtroom, no pun intended. Besides, you can get a free review of your case, courtesy of aforementioned aforementioned. The best part is you will be able to kick back and relax while a team of legal professionals assembles your case in record time. Besides, you won’t have to deal with a horde of hysterical lawyers, and a plethora of zealous patients. AstraZeneca is the smartest of the smart. One of the more sensible suits, namely Michael Levesque, is more than happy to oblige. Moreover, Levesque is a jack of all trades, master of all trades. Besides, he is also the best-kept secret of AstraZeneca. After all, he was a medical professional for most of his career. If he is the sexiest of the lot, you can expect an equally as dashing spouse. Lastly, as with any big boy, you are likely to run into a few bumps along the way, and a seasoned litigator is just the man for the job. Besides, you can’t beat the cost of a consult, and you will probably be dealing with the best of the best.

See also  The Best Mobile Cases for Android Users

Increased risk of pancreatitis

KOMBIGLYZE XR (saxagliptin and metformin hydrochloride) is a combination of two antihyperglycemic medications. It is approved by the U.S. Food and Drug Administration in November 2010. The combined components of KOMBIGLYZE XR have not been evaluated in lactation.

Patients are advised not to take more than the recommended dosage. If there is any severe abdominal pain, discontinue KOMBIGLYZE XR. If symptoms persist, call your health care provider. Your doctor may recommend a liver function test or ketoacidosis assessment. The risk of lactic acidosis is greater with dehydration and hepatic impairment.

There is an increased risk of pancreatitis with Kombiglyze XR. Patients with a history of pancreatitis are at a higher risk of developing this complication. Patients who have a history of pancreatic cancer may also be at risk. In addition, patients with a history of alcoholism are at a higher risk of developing pancreatitis.

Kombiglyze XR should be avoided in patients with hepatic impairment. Metformin is substantially excreted by the kidney. In addition, metformin-associated lactic acidosis has been reported in patients with hepatic impairment. These patients have a higher risk of developing lactic acidosis, and should be evaluated.

Patients should also be monitored for signs and symptoms of heart failure while they are on KOMBIGLYZE XR. Patients should be instructed to contact their health care provider if they develop heart failure, or if symptoms become worse. It is also important to discuss the importance of monitoring blood glucose, A1C, and cholesterol levels as well as dietary instructions.

If KOMBIGLYZE XR is used in children, the risk of pancreatitis may be increased. It is not known if this risk is related to the length of prescription or the amount of metformin used.

If you or a loved one has experienced side effects from Onglyza, you may be eligible for a free legal investigation. For more information, call an experienced pharmaceutical law attorney. You may also qualify for a free case evaluation.

Patients should be informed that they should not take KOMBIGLYZE XR if they have hepatic impairment or severe renal impairment. These patients should also be counseled against consuming excessive amounts of alcohol.

See also  Soone App Makes it Easy to Find Real-Life

Increased risk of cancer

Taking Kombiglyze XR may cause an increased risk of cancer. In fact, studies show that the drug can cause pre-cancerous cellular changes in the pancreas. In addition, researchers found that some patients with incretin-based therapies had pre-cancerous growths on their pancreas.

Researchers are not entirely sure what causes these problems. However, scientists do speculate that the drug may have a negative effect on heart rate and rhythm. These problems can lead to an increased risk of cancer and other diseases.

Kombiglyze XR is a prescription drug that is used to control blood sugar levels in adults with type 2 diabetes. It is also used as an adjunct to diet and exercise. It is made up of a compound called saxagliptin.

Kombiglyze XR can cause serious side effects, including heart failure. The drug may also cause lactic acidosis, a condition that can be fatal. People with heart problems and kidney problems are especially at risk of developing lactic acidosis. This condition can result in weakness, tremors, muscle pain, shortness of breath, and other problems.

Kombiglyze XR may also increase the risk of thyroid cancer. In addition, it may interact with dietary supplements and other medications. In order to protect yourself, you should always discuss taking this medication with a healthcare professional before starting treatment.

AstraZeneca, the company that manufactures Kombiglyze XR, is facing dozens of lawsuits. According to reports, people who developed heart failure after taking the drug may be eligible for a lawsuit against the drug’s manufacturer.

Kombiglyze XR has also been linked to an increased risk of pancreatitis, which can cause pancreatic cancer. People who are experiencing this disease should contact a medical professional immediately.

Onglyza, like Kombiglyze XR, has also been linked to an increased risk of heart failure. In fact, the FDA warned about the potential for harm caused by Onglyza in 2016. In response to these concerns, the FDA has ordered diabetes drug manufacturers to add a warning about heart failure to the drug’s labeling.

If you have been diagnosed with heart failure or pancreatitis after taking Kombiglyze XR, you may be eligible for a lawsuit against the manufacturer.